|
AU2012202255A1
|
|
Salts of 5-azacytidine
|
|
TW201035088A
|
|
Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
|
|
SG172857A1
|
|
Pyrrolopyrimidinyl axl kinase inhibitors
|
|
US2009285772A1
|
|
Quinoline derivatives for modulating DNA methylation
|
|
AU2008240188A1
|
|
Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
|
|
US2008226747A1
|
|
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
|
|
MX2009009117A
|
|
Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors.
|
|
US2009099106A1
|
|
Quinoline derivatives for modulating DNA methylation
|
|
NZ576234A
|
|
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
WO2008055233A1
|
|
Protein kinase inhibitors
|
|
EP2078008A2
|
|
Quinoline derivatives for modulating dna methylation
|
|
CN101535295A
|
|
Quinoline derivatives for modulating DNA methylation
|
|
US2006264439A1
|
|
Inhibitors of polo-like kinase-1
|
|
KR20080020602A
|
|
Protein kinase inhibitors
|
|
AU2005314023A1
|
|
Pharmaceutical formulations cytidine analogs and derivatives
|
|
US2007072796A1
|
|
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
|
EP1793675A2
|
|
Salts of decitabine
|
|
US2006205685A1
|
|
Azacytosine analogs and derivatives
|
|
US2006063735A1
|
|
Salts of 5-azacytidine
|
|
CA2538857A1
|
|
Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
|
